PT2467136E - Formulações de 4-metilpirazol - Google Patents

Formulações de 4-metilpirazol Download PDF

Info

Publication number
PT2467136E
PT2467136E PT108364720T PT10836472T PT2467136E PT 2467136 E PT2467136 E PT 2467136E PT 108364720 T PT108364720 T PT 108364720T PT 10836472 T PT10836472 T PT 10836472T PT 2467136 E PT2467136 E PT 2467136E
Authority
PT
Portugal
Prior art keywords
methylpyrazole
formulations
methylpyrazole formulations
Prior art date
Application number
PT108364720T
Other languages
English (en)
Inventor
Thomas E Daley
Kathy Powell
Olga Jarzebinski
Original Assignee
Raptor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptor Therapeutics Inc filed Critical Raptor Therapeutics Inc
Publication of PT2467136E publication Critical patent/PT2467136E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT108364720T 2009-12-07 2010-12-06 Formulações de 4-metilpirazol PT2467136E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26738909P 2009-12-07 2009-12-07

Publications (1)

Publication Number Publication Date
PT2467136E true PT2467136E (pt) 2014-08-26

Family

ID=44145870

Family Applications (2)

Application Number Title Priority Date Filing Date
PT108364720T PT2467136E (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol
PT141501387T PT2774612T (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT141501387T PT2774612T (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol

Country Status (13)

Country Link
US (2) US9173850B2 (pt)
EP (3) EP3300732A1 (pt)
JP (1) JP5678088B2 (pt)
KR (1) KR101464053B1 (pt)
CN (1) CN102630162B (pt)
AU (1) AU2010328375B2 (pt)
DK (2) DK2774612T3 (pt)
ES (2) ES2646201T3 (pt)
HK (1) HK1201759A1 (pt)
PT (2) PT2467136E (pt)
SG (2) SG181566A1 (pt)
TW (1) TWI490209B (pt)
WO (1) WO2011071805A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5800669B2 (ja) * 2011-10-18 2015-10-28 大阪化成株式会社 抗菌・抗カビ性付与剤、繊維類加工剤及び抗菌・抗カビ性繊維類の製造方法
EP3323412A1 (en) * 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole
KR102150040B1 (ko) * 2018-10-16 2020-08-31 한국과학기술원 4-메틸피라졸을 포함하는 간암 예방 또는 치료용 조성물
CN109452286B (zh) * 2018-11-12 2020-11-06 青岛大学 甲吡唑在杀灭松材线虫中的应用
CN109381458B (zh) * 2018-12-16 2020-09-01 李志武 甲吡唑及其盐在制备抗癫痫药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6120806A (en) 1997-06-25 2000-09-19 Whitmire; David R. Oral formulations for controlled release of alcohol deterrents
FR2807645B1 (fr) * 2000-04-12 2005-06-03 Oreal Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques
TWI324934B (en) 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
ITBO20020284A1 (it) 2002-05-14 2003-11-14 Ima Spa Macchina opercolatrice
US7082738B2 (en) 2002-07-05 2006-08-01 Shionogi Qualicaps Co., Ltd. Capsule-filling and sealing apparatus
DK1663217T3 (da) * 2003-08-29 2010-11-08 Lifecycle Pharma As Faste dispersioner indeholdende tacrolimus
EP1701697A2 (en) * 2003-09-02 2006-09-20 ALZA Corporation Novel drug compositions and dosage forms of topiramate
TW200534852A (en) * 2004-03-03 2005-11-01 Convivia 4-methylpyrazole formulations for inhibiting ethanol intolerance

Also Published As

Publication number Publication date
JP5678088B2 (ja) 2015-02-25
CN102630162B (zh) 2014-07-09
EP2467136A4 (en) 2013-01-16
ES2487634T3 (es) 2014-08-22
CN102630162A (zh) 2012-08-08
PT2774612T (pt) 2017-11-17
WO2011071805A1 (en) 2011-06-16
US9173850B2 (en) 2015-11-03
AU2010328375B2 (en) 2015-08-27
SG10201710156RA (en) 2018-01-30
TW201127816A (en) 2011-08-16
HK1201759A1 (en) 2015-09-11
EP2774612A1 (en) 2014-09-10
EP3300732A1 (en) 2018-04-04
TWI490209B (zh) 2015-07-01
KR20120115483A (ko) 2012-10-18
KR101464053B1 (ko) 2014-11-20
AU2010328375A1 (en) 2012-04-05
DK2467136T3 (da) 2014-08-11
ES2646201T3 (es) 2017-12-12
US20160151332A1 (en) 2016-06-02
JP2013512930A (ja) 2013-04-18
EP2467136A1 (en) 2012-06-27
EP2467136B1 (en) 2014-05-07
EP2774612B1 (en) 2017-08-30
US20120244217A1 (en) 2012-09-27
DK2774612T3 (da) 2017-11-20
SG181566A1 (en) 2012-07-30

Similar Documents

Publication Publication Date Title
ZA201106050B (en) Dye-polymers formulations
IL219961A0 (en) Abuse-resistant formulations
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
GB0823269D0 (en) Formulations
IL269369A (en) The vehicles are improved
GB0821789D0 (en) Formulations
GB0907003D0 (en) Formulation
GB0919210D0 (en) Formulations
EP2307021A4 (en) FORMULATIONS
HK1201759A1 (en) 4-methylpyrazole formulations 4-
EP2413905A4 (en) COMPOSITION
ZA201107435B (en) Pyrazole copmpound
IL217390A0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0911213D0 (en) Formulation
GB0822171D0 (en) Temisartan formulations
GB0917744D0 (en) Formulations
GB0914489D0 (en) Improved formulations
GB0817079D0 (en) Formulations
GB0807906D0 (en) Formulations
GB0823493D0 (en) Formulations
GB0816876D0 (en) Formulations
GB0916106D0 (en) Formulations